BusinessEpilepsy Foundation Testifies Before FDA Advisory Committee in Support of Potential First-Ever Cannabidiol Drug to Treat Dravet SyndromeBy Nasdaq OMXApr 19, 2018, 4:07 PM UTC
BusinessAdvanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation ScrewsBy Nasdaq OMXApr 19, 2018, 3:50 PM UTC
BusinessAmedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion DeviceBy Nasdaq OMXMar 6, 2018, 2:04 PM UTC
BusinessAXIM Biotech Announces Successful Completion of Pre-IND Meeting with FDA on Comparable Product to Marinol; Green Light from FDA for IND SubmissionBy Nasdaq OMXDec 12, 2017, 2:01 PM UTC
BusinessZomedica Announces Achievement of Therapeutic Development MilestonesBy Nasdaq OMXDec 12, 2017, 11:55 AM UTC
BusinessRitter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose IntoleranceBy Nasdaq OMXOct 3, 2017, 4:00 PM UTC
BusinessFDA Commissioner Scott Gottlieb to Deliver Keynote at RAPS Regulatory ConvergenceBy Nasdaq OMXJul 3, 2017, 1:00 PM UTC
